Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Breast (Edinburgh, Scotland)|January 20, 2026
The trajectory of fatigue over time in breast cancer patients treated with chemotherapy: exploring the effect of anthracycline-based chemotherapyAnneke Kastelein, Laura Kervezee, Dieuwke R Mink van der Molen, et al.
JCO Clinical Cancer Informatics|April 24, 2020
Impact on Quality of Documentation and Workload of the Introduction of a National Information Standard for Tumor Board ReportingKees C W J Ebben, Melle S Sieswerda, Ernest J T Luiten, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 18, 2026
Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancerEva L Claassens, Linetta B Koppert, Carmen C van der Pol, et al.
Clinical Breast Cancer|December 8, 2015
High Prevalence of MRI-Detected Contralateral and Ipsilateral Malignant Findings in Patients With Invasive Ductolobular Breast Cancer: Impact on Surgical ManagementMary-Ann El Sharouni, Emily L Postma, Gisela L G Menezes, et al.
Breast Cancer Research and Treatment|March 2, 2018
The risk of cardiovascular disease following breast cancer by Framingham risk scoreSofie A M Gernaat, Jolanda M A Boer, Desiree H J van den Bongard, et al.
Lymphatic Research and Biology|June 19, 2019
Compression Vest Treatment for Symptomatic Breast Edema in Women Treated for Breast Cancer: A Pilot StudyMadelijn L Gregorowitsch, Desirée H J G Van den Bongard, Marilot C T Batenburg, et al.
JNCI Cancer Spectrum|July 31, 2019
Breast Edema Following Breast-Conserving Surgery and Radiotherapy: Patient-Reported Prevalence, Determinants, and Effect on Health-Related Quality of LifeDanny A Young-Afat, Madelijn L Gregorowitsch, Desirée H van den Bongard, et al.
The British Journal of Surgery|September 20, 2024
Disease extent according to baseline [18F]fluorodeoxyglucose PET/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancerFlorien J G van Amstel, Cornelis M de Mooij, Janine M Simons, et al.
JMIR Cancer|April 15, 2017
Patients' and Health Care Providers' Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative EvaluationDanny A Young-Afat, Carla H van Gils, David J Bruinvels, et al.
BMC Cancer|June 27, 2022
Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer?Susana I S Patuleia, Cathy B Moelans, Jasmijn Koopman, et al.
Pageof 4